S&P 500 Outperformance, Risks, and What to Expect for 2025

Profit With the Pros: January 7, 2025 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  

Join us every Tuesday for Profit With the Pros, as we share some of our favorite stock market reports, articles, research, and trends. We'll curate a fresh batch of free, top-tier content from our exceptional team of traders, analysts, and editors, constructed to help you keep your portfolio at the top of its game.   Semiconductor Stocks Surge on Microsoft, Foxconn Buzz Artificial intelligence (AI) will continue to be a hot topic in 2025. Microsoft (MSFT) revealed plans to invest $80 billion in AI-powered data centers, and chip giant Foxconn saw a 15% year-over-year jump in revenue to $63.9 billion in the fourth quarter. Those headlines boosted semiconductor stocks, including industry giants Advanced Micro Devices (AMD), Taiwan Semiconductor Mfg. (TSM), and Micron Technology (MU), so let's dig into their short- and long-term performance. Free Chip Sector Breakdown   S&P 500 Technical Risks Keep Mounting: What to Know Senior V.P. of Research Todd Salamone boasts over 30 years of options trading experience, with appearances on CNBC, Bloomberg Television, Fox Business Network to go with quotes in The Wall Street Journal, Reuters, and the Associated Press. His Monday Morning Outlook is the perfect road map for traders that want to hit the ground running at the start of each trading week. In the first 'Outlook' of 2025, Todd pinpoints a S&P 500 technical pattern to watch, even amid a still heavily shorted market. Access This Free Report   A Biotech Stock on the Cusp of Transforming Antiviral Treatments (AD) NanoViricides, Inc. (NNVC)'s lead drug candidate NV-387 (drug product NV-CoV-2), a drug that treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Learn More Now   What Another Banner Performance Means for the SPX Dive into how the stock market has historically performed based on the prior year's returns, with Schaeffer's Senior Quantitative Analyst Rocky White! White will examine what history suggests we might expect from stocks this January, given the impressive S&P 500 Index (SPX) performance last year. Besides, who doesn't love an inside scoop for the fresh year ahead? What to Expect in 2025   Top Stock Picks for Your 2025 Portfolio To kick off the year, our team of traders at Schaeffer's compiled a list of Stock Picks for 2025. Both Boeing (BA) and Carvana (CVNA) made the cut, as they have long-term technical support on the charts. To learn more about why they're on the list, click below. 2 Stock Picks for 2025     Schaeffer's Investment Research  |  5151 Pfeiffer Road, Cincinnati, OH 45242 Unsubscribe